M. J. Hussain

Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma

I. Lossos, J. Cerhan, T. Habermann, 2018, British journal of haematology.

Clinical Relevance of Immunobiology in Umbilical Cord Blood Transplantation

M. J. Hussain, C. Brunstein, S. Nathan, 2019, Journal of clinical medicine.

DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD?

C. Ustun, M. J. Hussain, S. Nathan, 2019, Clinical lymphoma, myeloma & leukemia.

Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3-ITD-positive acute myeloid leukemia.

C. Ustun, M. J. Hussain, S. Nathan, 2019, Blood advances.

Maintenance Rituximab or Observation after Frontline Treatment with Bendamustine-Rituximab (BR) for Follicular Lymphoma: A Real World Analysis Across 13 US Cancer Centers

I. Lossos, J. Cerhan, T. Habermann, 2017 .

Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall Survival

I. Lossos, J. Cerhan, T. Habermann, 2018, Blood.